$PRO
PROS Holdings, Inc. Stock $pro

$pro Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000139297223000070 Filed on May 02, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$75.79M	$73.18M	$66.49M
YoY Change	10.87%	10.06%	8.33%
Cost Of Revenue	$28.57M	$29.54M	$27.36M
YoY Change	3.36%	7.97%	3.28%
Gross Profit	$47.22M	$43.64M	$39.13M
YoY Change	15.96%	11.52%	12.17%
Gross Profit Margin	62.3%	59.63%	58.85%
Selling, General & Admin	$38.73M	$40.15M	$39.62M
YoY Change	2.3%	1.34%	14.66%
% of Gross Profit	82.02%	91.99%	101.24%
Research & Development	$21.85M	$22.29M	$24.47M
YoY Change	-6.64%	-8.89%	16.93%
% of Gross Profit	46.27%	51.08%	62.53%
Depreciation & Amortization	$2.751M	$3.001M	$4.647M
YoY Change	-27.62%	-35.42%	51.47%
% of Gross Profit	5.83%	6.88%	11.88%
Operating Expenses	$60.58M	$62.44M	$64.08M
YoY Change	-1.11%	-2.57%	15.51%
Operating Profit	-$13.36M	-$18.80M	-$26.50M
YoY Change	-34.97%	-29.08%	28.72%
Interest Expense	-$1.576M	-$1.576M	-$1.576M
YoY Change	0.0%	0.0%	-0.25%
% of Operating Profit
Other Income/Expense, Net	$1.791M	$1.451M	-$418.0K
YoY Change	-89650.0%	-447.13%	-246.15%
Pretax Income	-$13.14M	-$18.92M	-$28.50M
YoY Change	-40.58%	-33.6%	30.24%
Income Tax	$149.0K	$81.00K	$143.0K
% Of Pretax Income
Net Earnings	-$13.29M	-$19.00M	-$28.64M
YoY Change	-40.69%	-33.65%	30.01%
Net Earnings / Revenue	-17.53%	-25.97%	-43.07%
Basic Earnings Per Share	-$0.29	-$0.41	-$0.64
Diluted Earnings Per Share	-$0.29	-$0.41	-$0.64
COMMON SHARES
Basic Shares Outstanding	46.04M shares	45.87M shares	45.09M shares
Diluted Shares Outstanding	46.10M shares	45.93M shares	45.09M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$184.6M	$192.4M	$217.4M
YoY Change	-14.23%	-11.51%	-32.88%
Cash & Equivalents	$184.6M	$192.4M	$217.4M
Short-Term Investments
Other Short-Term Assets	$17.63M	$18.58M	$16.60M
YoY Change	-1.46%	11.93%	0.01%
Inventory
Prepaid Expenses
Receivables	$54.16M	$45.79M	$52.80M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$256.4M	$256.7M	$286.8M
YoY Change	-4.16%	-10.48%	-27.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$38.71M	$25.44M	$28.14M
YoY Change	41.58%	-9.59%	-21.02%
Goodwill	$107.7M	$107.7M	$107.9M
YoY Change	0.36%	-0.2%	117.76%
Intangibles	$14.43M	$16.05M	$24.64M
YoY Change	-34.57%	-34.89%	230.03%
Long-Term Investments
YoY Change
Other Assets	$16.74M	$8.872M	$8.119M
YoY Change	105.27%	9.27%	8.18%
Total Long-Term Assets	$177.6M	$180.8M	$199.8M
YoY Change	-8.58%	-9.51%	41.77%
TOTAL ASSETS
Total Short-Term Assets	$256.4M	$256.7M	$286.8M
Total Long-Term Assets	$177.6M	$180.8M	$199.8M
Total Assets	$434.0M	$437.6M	$486.6M
YoY Change	-6.02%	-10.08%	-9.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.874M	$4.197M	$7.957M
YoY Change	14.99%	-47.25%	25.96%
Accrued Expenses	$38.76M	$13.36M	$12.39M
YoY Change	205.24%	7.81%	-25.97%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$143.0M
YoY Change
Total Short-Term Liabilities	$305.0M	$160.8M	$164.3M
YoY Change	94.1%	-2.08%	2.41%
LONG-TERM LIABILITIES
Long-Term Debt	$147.5M	$290.2M	$288.7M
YoY Change	-48.96%	0.52%	0.51%
Other Long-Term Liabilities	$32.90M	$1.247M	$1.182M
YoY Change	2989.01%	5.5%	-18.43%
Total Long-Term Liabilities	$180.4M	$1.247M	$1.182M
YoY Change	16840.85%	5.5%	-18.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$305.0M	$160.8M	$164.3M
Total Long-Term Liabilities	$180.4M	$1.247M	$1.182M
Total Liabilities	$485.4M	$485.5M	$499.4M
YoY Change	-0.29%	-2.78%	-0.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$623.2M	-$609.9M	-$537.3M
YoY Change	11.34%	13.51%	19.54%
Common Stock	$51.00K	$51.00K	$50.00K
YoY Change	2.0%	2.0%	2.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$29.85M	$29.85M	$29.85M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares			4.681M shares
Shareholders Equity	-$51.45M	-$47.97M	-$12.82M
YoY Change
Total Liabilities & Shareholders Equity	$434.0M	$437.6M	$486.6M
YoY Change	-6.02%	-10.08%	-9.06%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$13.29M	-$19.00M	-$28.64M
YoY Change	-40.69%	-33.65%	30.01%
Depreciation, Depletion And Amortization	$2.751M	$3.001M	$4.647M
YoY Change	-27.62%	-35.42%	51.47%
Cash From Operating Activities	-$6.542M	-$6.143M	-$11.01M
YoY Change	238.79%	-44.23%	148.68%
INVESTING ACTIVITIES
Capital Expenditures	$277.0K	$1.546M	$461.0K
YoY Change	-189.94%	235.36%	-64.54%
Acquisitions
YoY Change
Other Investing Activities	$0.00		$0.00
YoY Change	-100.0%		-100.0%
Cash From Investing Activities	-$277.0K	-$1.546M	-$461.0K
YoY Change	-41.93%	235.36%	-74.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-958.0K	-$3.573M	$1.231M
YoY Change		-390.25%	-1.05%
NET CHANGE
Cash From Operating Activities	-6.542M	-$6.143M	-$11.01M
Cash From Investing Activities	-277.0K	-$1.546M	-$461.0K
Cash From Financing Activities	-958.0K	-$3.573M	$1.231M
Net Change In Cash	-7.777M	-$11.25M	-$10.16M
YoY Change	222.97%	10.74%	95.2%
FREE CASH FLOW
Cash From Operating Activities	-$6.542M	-$6.143M	-$11.01M
Capital Expenditures	$277.0K	$1.546M	$461.0K
Free Cash Flow	-$6.819M	-$7.689M	-$11.48M
YoY Change	320.15%	-32.99%	100.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001392972
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-33554
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	PROS HOLDINGS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	76-0168604
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3200 Kirby Drive, Suite 600
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77098
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	City Area Code CityAreaCode	(713)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	335-5151
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock $0.001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	PRO
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46044260	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	192376000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	203627000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	722000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	609000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45787000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48178000	usd
CY2023Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	6433000	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	6032000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12149000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9441000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	256745000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	267278000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25442000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25012000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14797000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17474000	usd
CY2023Q1	us-gaap	Deferred Costs DeferredCosts	7938000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	8764000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16046000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17851000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	107717000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	107561000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8872000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9012000	usd
CY2023Q1	us-gaap	Assets Assets	437557000	usd
CY2022Q4	us-gaap	Assets Assets	452952000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4197000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7964000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13356000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12854000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	15624000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23797000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5461000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7662000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	122192000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	108659000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	160830000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	160936000	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	6161000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	8298000	usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	290152000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	289779000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27135000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	28184000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1247000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1228000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	485525000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	488425000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50711964	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50318726	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46031241	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45638003	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	51000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	50000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	596805000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	590475000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	4680723	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	4680723	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	29847000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	29847000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-609900000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-590898000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5077000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5253000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-47968000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-35473000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	437557000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	452952000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	73182000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	66492000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	29542000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	27361000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	43640000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	39131000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26010000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	25287000	usd
CY2023Q1	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	22291000	usd
CY2022Q1	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	24467000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14135000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14329000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1551000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-18796000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-26503000	usd
CY2023Q1	pro	Convertibledebtinterestandamortization Convertibledebtinterestandamortization	1576000	usd
CY2022Q1	pro	Convertibledebtinterestandamortization Convertibledebtinterestandamortization	1576000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1451000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-418000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18921000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28497000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	81000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	143000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-19002000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-28640000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Outstanding Limited Partnership And General Partnership Unit Basic And Diluted IncomeLossFromContinuingOperationsPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted	-0.41
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Outstanding Limited Partnership And General Partnership Unit Basic And Diluted IncomeLossFromContinuingOperationsPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted	-0.64
CY2023Q1	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	45926000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	45085000	shares
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	176000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-222000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	176000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-222000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18826000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28862000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-19002000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-28640000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3001000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4647000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	373000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	373000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9904000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11225000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	108000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-91000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-35000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1551000	usd
CY2023Q1	pro	Accounts And Unbilled Receivables AccountsAndUnbilledReceivables	-2239000	usd
CY2022Q1	pro	Accounts And Unbilled Receivables AccountsAndUnbilledReceivables	12130000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-425000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	48000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2505000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	262000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	591000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	739000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3793000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3903000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	504000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-109000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-8174000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-13246000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	11333000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	22552000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6143000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11014000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1546000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	461000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1546000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-461000	usd
CY2023Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1137000	usd
CY2022Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1443000	usd
CY2023Q1	pro	Tax Withholding Related To Net Share Settlement Of Restricted Stock Units TaxWithholdingRelatedToNetShareSettlementOfRestrictedStockUnits	4710000	usd
CY2022Q1	pro	Tax Withholding Related To Net Share Settlement Of Restricted Stock Units TaxWithholdingRelatedToNetShareSettlementOfRestrictedStockUnits	212000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3573000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1231000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11251000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10160000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	203627000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	227553000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	192376000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	217393000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	136000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	45000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-35473000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-4710000	usd
CY2023Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1137000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9904000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	176000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-19002000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-47968000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3584000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-212000	usd
CY2022Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1443000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11225000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-222000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-28640000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-12822000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	Organization and Nature of Operations<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROS Holdings, Inc., a Delaware corporation, through its operating subsidiaries (collectively, the "Company"), provides solutions that optimize shopping and selling experiences. PROS solutions leverage artificial intelligence ("AI"), self-learning and automation to ensure that every transactional experience is fast, frictionless and personalized for every shopper, supporting both business-to-business ("B2B") and business-to-consumer ("B2C") companies across industry verticals. Companies can use these selling, pricing, revenue optimization, distribution and retail, and digital offer marketing solutions to assess their market environments in real time to deliver customized prices and offers. The Company's solutions enable their customers to provide the buyers of their products the ability to move fluidly from one sales channel to another, whether direct, partner, online, mobile or other emerging channels, each with a personalized experience regardless of which channel is used. The Company's decades of data science and AI expertise are infused into its solutions and are designed to reduce time and complexity through actionable intelligence.</span></div>
CY2023Q1	pro	Treasury Money Market Funds At Fair Value TreasuryMoneyMarketFundsAtFairValue	176500000	usd
CY2022Q4	pro	Treasury Money Market Funds At Fair Value TreasuryMoneyMarketFundsAtFairValue	168100000	usd
CY2023Q1	us-gaap	Revenue Recognition Customer Acquisitions RevenueRecognitionCustomerAcquisitions	<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred costs</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions earned by the Company's sales representatives are considered incremental and recoverable costs of obtaining a customer contract. Sales commissions are deferred and amortized on a straight-line basis over the period of benefit, which the Company has determined to be five to eight years. The Company determined the period of benefit by taking into consideration its customer contracts, expected renewals of those customer contracts (as the Company currently does not pay an incremental sales commission for renewals), the Company's technology and other factors. The Company also defers amounts earned by employees other than sales representatives who earn incentive payments under compensation plans also tied to the value of customer contracts acquired. Deferred costs were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$14.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$14.8 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of March 31, 2023 and December 31, 2022, respectively. Amortization expense for the deferred costs was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.5 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $1.4 million for the three months ended March 31, 2023 and 2022, respectively. Amortization of deferred costs is included in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">selling and marketing expense in the accompanying unaudited condensed consolidated statements of comprehensive loss.</span></div>
CY2023Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	14400000	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	14800000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	1500000	usd
CY2022Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	1400000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	1500000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	1600000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	200000	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	300000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	49400000	usd
CY2022Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	44300000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	430600000	usd
CY2023Q1	pro	Revenue Remaining Performance Obligationtoberecognizedwithin12months RevenueRemainingPerformanceObligationtoberecognizedwithin12months	210000000	usd
CY2023Q1	us-gaap	Revenues Revenues	73182000	usd
CY2023Q1	pro	Percentage Of Total Revenue PercentageOfTotalRevenue	1
CY2022Q1	us-gaap	Revenues Revenues	66492000	usd
CY2022Q1	pro	Percentage Of Total Revenue PercentageOfTotalRevenue	1
CY2023Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P15Y
CY2023Q1	pro	Lessee Operating Lease Termination Option LesseeOperatingLeaseTerminationOption	P1Y
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2251000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1842000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	pro	Decrease In Right Of Use Asset And Related Lease Liability Due To Modification DecreaseInRightOfUseAssetAndRelatedLeaseLiabilityDueToModification	1000000	usd
CY2022Q1	pro	Decrease In Right Of Use Asset And Related Lease Liability Due To Modification DecreaseInRightOfUseAssetAndRelatedLeaseLiabilityDueToModification	2700000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	6649000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4869000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4057000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4039000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3965000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	4029000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	19223000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	46831000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14235000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	32596000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-19002000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-28640000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45926000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45085000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45926000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45085000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.64
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.64
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9904000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11225000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	100700000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2023Q1	pro	Sharebasedcompensationarrangementbysharebasedpayment Minimum Employee Subscriptionrate SharebasedcompensationarrangementbysharebasedpaymentMinimumEmployeeSubscriptionrate	0.01
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate	0.10
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate	0.15
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate	0.15
CY2023Q1	pro	Maximum Amount Contributablebyemployeesunder Espp Halfyearly MaximumAmountContributablebyemployeesunderESPPHalfyearly	5000	usd
CY2023Q1	pro	Maximum Amount Contributable By Employees Under Espp Annually MaximumAmountContributableByEmployeesUnderESPPAnnually	10000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	55149	shares
CY2023Q1	pro	Esp Pcontributionsby Employees ESPPcontributionsbyEmployees	700000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	192400000	usd
CY2023Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	277300000	usd
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	263700000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	293750000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	293750000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3598000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3971000	usd
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	290152000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	289779000	usd
CY2023Q1	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	1203000	usd
CY2022Q1	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	1203000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	373000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	373000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1576000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1576000	usd
CY2023Q1	us-gaap	Severance Costs1 SeveranceCosts1	3600000	usd
CY2023Q1	pro	Cash Payments For Severance And Other Related CashPaymentsForSeveranceAndOtherRelated	3200000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	1300000	usd

Files In Submission

Name	View Source	Status
0001392972-23-000070-index-headers.html	Edgar Link	pending
0001392972-23-000070-index.html	Edgar Link	pending
0001392972-23-000070.txt	Edgar Link	pending
0001392972-23-000070-xbrl.zip	Edgar Link	pending
a2023q1ex311ceocertificati.htm	Edgar Link	pending
a2023q1ex312cfocertificati.htm	Edgar Link	pending
a2023q1ex321ceocfocertific.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pro-20230331.htm	Edgar Link	pending
pro-20230331.xsd	Edgar Link	pending
pro-20230331_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
pro-20230331_cal.xml	Edgar Link	unprocessable
pro-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
pro-20230331_lab.xml	Edgar Link	unprocessable
pro-20230331_pre.xml	Edgar Link	unprocessable
pro-20230331_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRO
PROS Holdings, Inc. Stock $pro

2023 Q2 Form 10-Q Financial Statement

#000139297223000070 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRO PROS Holdings, Inc. Stock $pro

2023 Q2 Form 10-Q Financial Statement

#000139297223000070 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRO
PROS Holdings, Inc. Stock $pro